VECTOFUSIN Trademark

Trademark Overview

On Tuesday, June 26, 2012, a trademark application was filed for VECTOFUSIN with the United States Patent and Trademark Office. The USPTO has given the VECTOFUSIN trademark a serial number of 79117575. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Tuesday, March 12, 2024. This trademark is owned by GENETHON. The VECTOFUSIN trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Biological and chemical products used in the pharmaceutical and life sciences field, namely, reagents for gene transfer, [diagnostics, ] viral detection, and for the preparation of pharmaceutical products used in gene and cell therapy; Pharmaceutical, chemical and chemical-pharmaceutical products for use in gene and cell therapy; Micro-organism cultures used in the research, development and production of medicines

[ Scientific and technological research services, namely, research and development of new products, scientific research for medical purposes, research in the fields of chemistry and biology ]
vectofusin

General Information

Serial Number79117575
Word MarkVECTOFUSIN
Filing DateTuesday, June 26, 2012
Status706 - SECTION 71 ACCEPTED
Status DateTuesday, March 12, 2024
Registration Number4381675
Registration DateTuesday, August 13, 2013
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 28, 2013

Trademark Statements

Goods and ServicesBiological and chemical products used in the pharmaceutical and life sciences field, namely, reagents for gene transfer, [diagnostics, ] viral detection, and for the preparation of pharmaceutical products used in gene and cell therapy; Pharmaceutical, chemical and chemical-pharmaceutical products for use in gene and cell therapy; Micro-organism cultures used in the research, development and production of medicines
Goods and Services[ Scientific and technological research services, namely, research and development of new products, scientific research for medical purposes, research in the fields of chemistry and biology ]

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 1, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeG - NOT AVAILABLE
Class Status DateTuesday, June 18, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGENETHON
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressF-91000 EVRY
FR
Party NameGENETHON
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressF-91000 EVRY
FR
Party NameGENETHON
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressF-91000 EVRY
FR

Trademark Events

Event DateEvent Description
Monday, October 1, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 27, 2012SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, October 5, 2012APPLICATION FILING RECEIPT MAILED
Tuesday, October 16, 2012ASSIGNED TO EXAMINER
Tuesday, October 16, 2012NON-FINAL ACTION WRITTEN
Wednesday, October 17, 2012NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, October 17, 2012REFUSAL PROCESSED BY MPU
Wednesday, October 17, 2012NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, November 16, 2012REFUSAL PROCESSED BY IB
Sunday, March 24, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, March 24, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 25, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 27, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 11, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 24, 2013ASSIGNED TO LIE
Wednesday, April 24, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 8, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 28, 2013PUBLISHED FOR OPPOSITION
Tuesday, May 28, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 13, 2013REGISTERED-PRINCIPAL REGISTER
Wednesday, November 13, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, November 14, 2013FINAL DISPOSITION PROCESSED
Friday, November 15, 2013FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, June 18, 2019NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Tuesday, December 24, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, August 13, 2018COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, June 4, 2019TEAS SECTION 71 & 15 RECEIVED
Wednesday, June 12, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, June 18, 2019REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Tuesday, February 18, 2020PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Wednesday, May 13, 2020INVALIDATION PROCESSED
Wednesday, May 13, 2020PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, June 19, 2020PARTIAL INVALIDATION PROCESSED BY THE IB
Friday, July 15, 2022INTERNATIONAL REGISTRATION RENEWED
Saturday, August 13, 2022COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Thursday, June 22, 2023TEAS SECTION 71 RECEIVED
Friday, March 1, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, March 12, 2024NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Tuesday, March 12, 2024REGISTERED-SEC.71 ACCEPTED
Wednesday, November 13, 2024PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Wednesday, December 4, 2024INVALIDATION PROCESSED
Wednesday, December 4, 2024PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, January 10, 2025PARTIAL INVALIDATION PROCESSED BY THE IB

Related Keywords

vectofusin research products pharmaceutical used gene chemical therapy scientific development cell